Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Single-Cell Genome Sequencing Market Size Changed, over the years?
The market size for single-cell genome sequencing has seen a swift expansion in recent periods. It is projected to increase from $2.49 billion in 2024 to $2.84 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.9%. Factors behind the growth during the historical period include a heightened knowledge of genetic heterogeneity, a growing demand for precision medicine, a rise in cancer research, an upturn in the prevalence of infectious diseases, and a boost in healthcare spending.
How Much Will the Single-Cell Genome Sequencing Market Be Worth in 2029?
The market for single-cell genome sequencing is projected to experience a steep incline in growth over the next few years, culminating in a market size of $5.04 billion by 2029, accelerating at a compound annual growth rate (CAGR) of 15.4%. This surge during the forecast period can be attributed to several factors such as the rising occurrence of autoimmune diseases, an increase in neurological disorders, augmented governmental initiatives and funding, the rise in contract research organizations (CROs), and heightened awareness of the potential of scrna-seq. The key trends anticipated during the forecast period include the advancement in single-cell sequencing technologies, the advent of single-cell multi-omics technologies, alliances to fast-track advancement, the introduction of innovative solutions, and partnerships among key players in the market.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12655&type=smp
Which is the Largest Company in the Single-Cell Genome Sequencing Market?
Major companies operating in the single-cell genome sequencing market include F Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., DH Life Sciences LLC., Becton Dickinson And Company (BD), Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, Bio-Techne Corporation, BGI Genomics Co. Ltd., Fulgent Genetics Inc., 10x Genomics Inc., Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc., Standard BioTools Inc., Singleron Biotechnologies, MGI Tech Co. Ltd, GENEWIZ Inc., Mission Bio Inc., Zymo Research Corporation, Menarini Silicon Biosystems SpA, Novogene Co. Ltd., RareCyte Inc., Fluxion Biosciences Inc., Single Cell Discoveries B.V., Parse Biosciences Inc., BioSpyder Technologies Inc., SeqWell Inc.
What Are the Main Market Drivers in the Single-Cell Genome Sequencing Industry?
The surge in cancer cases is anticipated to drive the expansion of the single-cell genome sequencing market. Cancer, an umbrella term for diseases characterized by uncontrolled growth and division of abnormal cells, stems from genetic alterations that disrupt cell division and normal cell functioning. With its capability to detect these genetic changes in individual cancer cells, single-cell genome sequencing could be integral in understanding and treating cancer. For instance, the American Cancer Society reported about 1.9 million new cancer cases and 609,360 cancer-related fatalities in the US in 2022 as of January 2023. Moreover, an approximated 27.5 million new cancer diagnoses and 16.3 million cancer deaths are projected by 2040. Consequently, the escalating incidence of cancer is predicted to push the growth of the single-cell genome sequencing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12655&type=smp
How Is the Single-Cell Genome Sequencing Market Segments Structured?
The single-cell genome sequencing market covered in this report is segmented –
1) By Type: Instruments, Reagents
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Quantitative Polymerase Chain Reaction (qPCR), Microarray, Multiple Displacement Amplification (MDA)
3) By Disease Area: Cancer, Immunology, Prenatal Diagnosis, Neurobiology, Microbiology, Other Disease Areas
4) By Application: Circulating Cells, Cell Differentiation Or Reprogramming, Genomic Variation, Subpopulation Characterization, Other Applications
5) By End User: Academic Research Laboratories, Biotechnology Biopharmaceutical Companies, Clinics, Other End Users
Subsegments:
1) By Instruments: Single-Cell Isolation Systems, Sequencing Platforms, Automation And Robotic Systems
2) By Reagents: Library Preparation Kits, Amplification Reagents, DNA Extraction Kits, Quality Control Reagents
What Strategic Trends Are Transforming the Single-Cell Genome Sequencing Market?
Innovations in technology are emerging as a significant trend in the single-cell genome sequencing market. The key players in this market are zeroing in on devising technologically superior solutions to consolidate their market standing. For example, in May 2023, Mission Bio Inc., a U.S. firm with a single-cell multi-omics platform for integrating genotype and phenotype for cancer research and biomarker development, rolled out Tapestri Genome Editing Solution. This fresh product offering is for the analysis of genome editing and is expected to provide a more potent analytical mechanism. It is set to prop up the creation of next-gen gene-edited drugs by allowing single-cell insights that can alter efficacy and safety.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report
Which Global Regions Offer the Highest Growth in the Single-Cell Genome Sequencing Market?
North America was the largest region in the single-cell genome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell genome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12655
This Report Delivers Insight On:
1. How big is the single-cell genome sequencing market, and how is it changing globally?
2. Who are the major companies in the single-cell genome sequencing market, and how are they performing?
3. What are the key opportunities and risks in the single-cell genome sequencing market right now?
4. Which products or customer segments are growing the most in the single-cell genome sequencing market?
5. What factors are helping or slowing down the growth of the single-cell genome sequencing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
